Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-049425
Filing Date
2023-09-22
Accepted
2023-09-22 16:05:16
Documents
13
Period of Report
2023-08-16
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A onvo-20230816.htm   iXBRL 8-K/A 68622
2 EX-10.1 onvo-ex10_1.htm EX-10.1 46923
  Complete submission text file 0000950170-23-049425.txt   252094

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onvo-20230816.xsd EX-101.SCH 2474
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onvo-20230816_lab.xml EX-101.LAB 13878
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onvo-20230816_pre.xml EX-101.PRE 11428
7 EXTRACTED XBRL INSTANCE DOCUMENT onvo-20230816_htm.xml XML 5255
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 001-35996 | Film No.: 231271730
SIC: 2836 Biological Products, (No Diagnostic Substances)